# Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

> **NCT02177357** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 150 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Pramipexole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02177357
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-11
- **Primary completion:** 2000-01
- **Final completion:** —
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02177357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02177357, "Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02177357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*